Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN2C7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,266
Award facts
- Contract value 100% obligated
- $10,266.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,266.44 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of February 5, 2026, issued on February 4, 2026. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this order. Stelara is a specialty immunosuppressant medication used in the treatment of various autoimmune and inflammatory conditions, representing the type of pharmaceutical commodity critical to military and federal healthcare operations.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This primary vehicle enables the supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The structure of this delivery order exemplifies Cencora's ongoing role as a critical vendor in the federal pharmaceutical supply chain, particularly for the Defense Health Agency and other military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FN2C7?
SPE2DR26FN2C7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FN2C7 worth?
The government has obligated $10,266 on SPE2DR26FN2C7.
Is contract SPE2DR26FN2C7 an order under another contract?
Yes. SPE2DR26FN2C7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN2C7 competed?
The extent of competition for SPE2DR26FN2C7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award